RK

Rakesh Kumari Mahajan

Active Director Director DIN 00977741
DIN 00977741 First appointment Nov 2006 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Kumari Mahajan

Data last updated:

Rakesh Kumari Mahajan is a Director at Impetus Pharmaceuticals Private Limited (since 2006). The company operates in Home Appliances.

DIN 00977741
Primary Designation Director
Industry Home Appliances
First Appointment 01 Nov 2006
Oldest Company Age 23 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 20062003Active

Directorship timeline

Open interactive timeline →
Impetus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Kumari Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kumari Mahajan

Rakesh Kumari Mahajan currently holds 1 directorship: Impetus Pharmaceuticals Private Limited (Director, since 01 Nov 2006).

Rakesh Kumari Mahajan was first appointed on 01 Nov 2006 as Director at Impetus Pharmaceuticals Private Limited.

The current boards of Rakesh Kumari Mahajan's companies include Santosh Mahajan (Impetus Pharmaceuticals Private Limited), Shuchi Mahajan (Impetus Pharmaceuticals Private Limited), Vikram Bhardwaj (Impetus Pharmaceuticals Private Limited), Vishav Deep Bhardwaj (Impetus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available